Laurence Charney Insider Profile
11 Followers
Laurence Charney, Director at TG Therapeutics, holds 168.64K shares in TG Therapeutics (Ticker: TGTX), holds 21.43K shares in Iconix Brand (Ticker: ~ICON). Most recently, Laurence Charney Sold ― shares of TG Therapeutics on Sep 14, 2026 for an estimated value of $274.80K.
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-56.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Laurence Charney's holdings
Insider Roles
Director
Roles that Laurence Charney holds in companies
Most Profitable Insider Trade
The most profitable trade made by Laurence Charney
Laurence Charney's Trading History
TG Therapeutics
Sep 14, 2026
Director
Informative Sell
274.80K
$9.09M
Iconix Brand
Jan 03, 2013
―
Uninformative Buy
―
$67.52K
List of latest transactions for each holding click on a transaction to see Laurence Charney's performance on stock
You May Also Like
Laurence Charney insider profile FAQ
What is the percentage of profitable transactions made by Laurence Charney?
The percentage of profitable transactions made by Laurence Charney is 0%.
What is the average return per transaction made by Laurence Charney?
The average return per transaction made by Laurence Charney is -56.10%.
What stocks does Laurence Charney hold?
Laurence Charney holds: TGTX, ~ICON stocks.
What was Laurence Charney’s latest transaction?
Laurence Charney latest transaction was an Informative Sell of $274.80K.
What was Laurence Charney's most profitable transaction?
Laurence Charney’s most profitable transaction was an Informative Sell of TGTX stock on November 12, 2024. The return on the trade was -0.30%.
What is Laurence Charney's role in TG Therapeutics?
Laurence Charney's role in TG Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.